Skip to content

Current Treatment Strategy of Patients With Multivessel Disease or Left Main Coronary Artery Disease Indicated for Coronary Artery Bypass Graft Surgery

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02410993
Enrollment
2500
Registered
2015-04-08
Start date
2015-04-30
Completion date
2020-03-31
Last updated
2018-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Brief summary

According to 2011 ACCF/AHA guideline and 2014 ESC/EACTS guideline, CABG surgery was recommended for three-vessel coronary artery disease and left main coronary artery disease in the patients with stable ischemic heart disease as class I. 2-VD with proximal left anterior descending artery stenosis was also indicated for CABG surgery as class I recommendation. However, many patients have been recommended for PCI by catheterization laboratory cardiologist; 46% and 93% in the only-CABG candidates and both CABG and PCI candidates, retrospectively, defined by previous ACC/AHA guideline. Although the discordance between real practice in catheterization laboratory and guideline would be adjusted by recently updated guideline. The revascularization strategy for patients with 3-VD/LMD in real practice have been getting toward more PCI and less CABG surgery. In this study, we will identify the rate of CABG candidates who were treated with PCI or medical treatment instead of CABG surgery in different from current guideline. We are also going to compare two treatment strategies CABG surgery vs. PCI with 2nd generation DES regarding clinical outcomes.

Interventions

PROCEDURECABG surgery

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients ≥ 19 years old * Left main disease, three-vessel disease or two-vessel disease with proximal LAD stenosis.

Exclusion criteria

* Previous PCI within 1 year * Previous sternotomy * Primary PCI for STEMI * Contraindication or hypersensitivity to anti-platelet medications or contrast media * Planned need for concomitant other cardiac surgery (eg, valve surgery or resection of aortic or left ventricular aneurysm, etc) * Pregnant women or women with potential childbearing * Inability to follow the patient over the period of 1 year after enrollment, as assessed by the investigator * Inability to understand or read the informed content

Design outcomes

Primary

MeasureTime frame
Proportion of patients treated with PCI or medical treatment despite of recommendation for CABG surgery1 month (After the revascularization strategy was finally decided)

Secondary

MeasureTime frame
Reason of ineligibility for CABG surgery1 month (After the revascularization strategy was finally decided)
the composite of major cardiac and cerebrovascular event (MACCE)1 year follow up after revascularization

Countries

South Korea

Contacts

Primary ContactMyeong Ki Hong, MD, PhD
mkhong61@yuhs.ac82-2-2228-8460

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026